World Trade Factory™

Johnson & Johnson outlines orthopaedics spin-off and targets 5.7% reported sales growth for 2025 amid accelerating MedTech and Innovative Medicine momentum (NYSE:JNJ)

Johnson & Johnson outlines orthopaedics spin-off and targets 5.7% reported sales growth for 2025 amid accelerating MedTech and Innovative Medicine momentum (NYSE:JNJ)

Get key insights on Johnson & Johnson's Q3 2025 earnings, growth strategy, and Orthopaedics spin-off.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.